Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-720-6 | CAS number: 3586-55-8
A study on repeated dose toxicity according to OECD 408 in rats has been performed. In this subchronic gavage study pathological examinations included also reproductive organs in males and females. No treatment related effects were observed even at a dose level of 270 mg/kg bw/day inducing severe local effects and systemic effects secondary to the ulcerative gastritis & peritonitis. Moreover, it is assumed that test substance hydrolyses rapidly within the body and data for hydrolysis product are relevant for this endpoint. Systemic effects on reproduction are not expected after repeated dermal exposure of humans.
Data on toxicity to fertility of the products of hydrolysis are presented below.
The reproductive toxicity of ethylene glycol following ingestion has been investigated in a three-generation study in rats (DePass et al., 1986). The study was non GLP and non guideline but was carried out using similar methods to OECD Test Guideline 416. In the study, young adult F 344 rats aged approximately 7 weeks were fed diets containing ethylene glycol at either 0, 40, 200 or 1000 mg/kg bw/day. When the rats were approximately aged 14 weeks, 10 males were mated to 20 females in each dosage group (F0 generation). Litter size was randomly reduced to 10, if necessary, on day 4 postpartum. F1 rats were randomly selected within each dose group for the next mating. The F1 and F2 rats were administered ethylene glycol in the diet at either 0, 40, 200 or 1000 mg/kg bw/day from approximately 7 weeks of age and were mated at approximately 14 weeks of age. No effects on fertility were observed in any of the three generations of rats exposed to ethylene glycol orally at doses up to 1000 mg/kg bw/day. The NOAEL for the reproductive effects of ethylene glycol in rats exposed orally was therefore >1000 mg/kg bw/day (i.e. the highest dose tested). No adverse effects on the reproductive organs have been observed in adequate chronic oral dose toxicity studies in rats and mice (DePass et al, 1986).
The data for formaldehyde are presented as additional information. The effects are summarised there.
Data on formaldehyde
In a two-years drinking-water study of formaldehyde in rats (Til et al. 1989), which is comparable with OECD guideline 453, no adverse effects on the reproductive organs were recorded even at the high dose level of 109 mg/kg bw/day in males and 82 mg/kg bw/day in females inducing local effects in the stomach. These results are confirmed by Tobe et al. (1989) and further oral and inhalation studies in rats, mice and dogs.
Ward et al. (1984) investigated sperm count, morphology and fluorescent body frequency in occupationally exposed workers. No significant differences between exposed and non-exposed subjects were measured; however, the small number of subjects limited the detection power. In a study on women exposed to formaldehyde in the high exposure group, a longer time to pregnancy was reported (Collins et al. 2001).
No studies were available which are directly related to this endpoint (e.g. OECD guideline 415, 416, or 422). However, no studies are needed because it is not to be expected, that formaldehyde reaches the reproductive organs and there is no evidence for effects on fertility in experimental animals after oral or inhalation exposure. No conclusions can be drawn from the limited data in humans.
Evidence from published studies in rodents exposed to ethylene glycol via oral gavage during gestation suggests a consistent pattern of developmental effects including reduced fetal body weight and increases in malformations, particularly axial skeletal malformations, indicating that the developing fetus is a target for toxicity after oral exposures. Effects were observed at doses at which maternal toxicity was not observed. A single study of dermal exposure to ethylene glycol in pregnant mice did not indicate developmental effects. Reliable developmental studies following inhalation exposures to ethylene glycol are not available. Of the available studies, the study by Neeper-Bradley et al. is considered to be well-conducted. The study in mice identified the lowest LOAEL for developmental effects.
The NOAEL for the maternal toxicity of ethylene glycol in mice was considered to be >1500 mg/kg bw/day (i.e. > the highest dose used in the study). The NOAEL for the developmental toxicity of ethylene glycol in mice was considered to 150 mg/kg bw/day based on reduced body weights and increased incidence of total malformations and bilateral extra ribs at 500 mg/kg bw/day.
Rats exposed to 0, 2, 5, 10 ppm formaldehyde for 6 h/day at gestation day 6-15 showed maternal toxicity (reduced weight gain) at the high dose level. However, no embryo- or fetotoxic effects and no external, visceral or skeletal malformations were reported at any dose level (Martin 1990). Even at doses up to 40 ppm (6 h/days at gestation day 6-20) no teratogenic effects were detected in rats; only effects on foetal weight are reported at ≥ 20 ppm (Saillenfait et al. 1989). However, at these dose levels maternal toxicity is obvious due to irritation of the upper respiratory tract in dams (OECD 2002). In a feeding study on Beagle dogs 3.1 or 9.4 mg/kg bw/day on day 4 to 56 after mating resulted in no external malformations nor embryo- or foetotoxic effects. No maternal toxicity was reported (but no data given on maternal weight gain; Hurni & Ohder 1973). In a developmental toxicity study on mice no embryo- or fetotoxic effects were reported after oral exposure at dose levels resulting in maternal toxicity (Marks et al. 1980).
There were inconsistent findings in epidemiological studies on spontaneous abortions; however, no conclusion can be drawn due to limitations of these studies (Collins et al. 2001).
There is no evidence for adverse effects of formaldehyde on embryo and foetal development at dose levels inducing no local maternal toxicity.
Supporting information indicates that following maternal exposures to ethylene glycol the metabolite, glycolic acid, is the primary developmental toxicant in rodents. The inverted yolk sac placenta, a stage in placental development that does not exist in humans or in rabbits, tends to concentrate weak acids such as glycolic acid in the embryonic fluids. The data suggest that rodents have a greater sensitivity towards the developmental toxicity of ethylene glycol than humans or rabbits, on account of the tendency for glycolic acid to accumulate in the inverted yolk sac stage. There is no evidence to indicate that ethylene glycol has the potential to exert developmental toxicity in humans: human embryo development does not involve an inverted yolk stage and accumulation of glycolic acid is therefore unlikely.
Classification, Labeling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. According to Regulation (EC) No 1272/2008, the hydrolysis products ethylene glycol and formaldehyde are currently not classified for developmental toxicity. Based on these data, the substance is not considered to be classified for toxicity to reproduction under Regulation (EC) No 1272/2008, as amended for the tenth time in Regulation (EC) No 2017/776.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again